RNA Transcriptomics Market Report mainly improves market size,and provide detailed product mapping and investigation of various market scenarios. Our expert analysts provide a thorough analysis and breakdown of the market presence of key market leaders. We strive to stay updated with the recent developments and follow the latest company news related to the industry players operating in the global RNA Transcriptomics market. This helps us to comprehensively analyze the individual standing of the companies as well as the competitive landscape. Our vendor landscape analysis offers a complete study to help you gain the upper hand in the competition.
Get a Free sample of the report : https://www.emergenresearch.com/request-sample/610
Transcriptomics has a variety of applications in diagnostics and disease analysis. Transcriptome analysis has been widely used to study heterogeneity of tumors, classify tumors into molecular subtypes, and examine treatment therapy and patient outcomes.Commonly applied transcriptome analysis methods are hybridization-based microarray, real-time PCR, NGS-based RNA-sequencing (RNA-seq) methods, RNA interference, and bioinformatics tools. Growing need to analyze a large number of genes to better understand gene-to-drug interactions is expected to increase the application of transcriptomic technologies in drug development and discovery applications
A novel research report on global RNA Transcriptomics has been recently published by Emergen Research to offer a comprehensive overview of the industry with latest and emerging market trends between 2021 and 2028. The report offers a detailed overview of the market with precise information about product type, application, market size, revenue share, key drivers, restraints, opportunities, and challenges. The report also assesses market trends that can have favorable impact on the market in the coming years along with detailed examination of various market segments on global and regional levels.
In October 2019, Ambry Genetics introduced a transcriptomic test +RNAinsight, which allows clinicians to simultaneously perform RNA and DNA testing and identify the risk of genetic mutations that may develop cancer.
Reagents segment is expected to register a revenue CAGR of 14.0% over the forecast period. This can be attributed to rising demand for high-quality reagents and growing research and development activities in the pharmaceutical sector.
Asia Pacific market revenue is expected to continue to register the fastest CAGR throughout the forecast period, which can be attributed to rising number of biotechnology and pharmaceutical companies and increasing focus on drug development.
Key players operating in the market are Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., Illumina, Inc., GenXPro GmbH, Fluidigm Corporation, CD Genomics, Sequentia Biotech SL, and Acobiom.
Request customization of the report: https://www.emergenresearch.com/request-for-customization/610
Key points discussed in the report for Global RNA Transcriptomics Market:
Chapter 1: Introduction, market driving force product, Objectives of the Study, and Research Scope of the RNA Transcriptomics market
Chapter 2: Exclusive Summary –vital information of the RNA Transcriptomics Market.
Chapter 3: Market Dynamics- Drivers, Trends, and Challenges of the RNA Transcriptomics Market
Chapter 4: RNA Transcriptomics Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Market segmentation by Type, End-User and Region 2016-2018
Chapter 6: Analysis of the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions.
Chapter 7 & 8: Appendix, Methodology and Data Source…Continued
Finally, RNA Transcriptomics Market is a valuable source of guidance for individuals and companies.
For the purpose of this report, Emergen Research has segmented the global RNA transcriptomics market based on product, technology, application, end-use, and region:
Product Outlook (Revenue: USD Billion; 2018–2028)
- Reagents
- Instruments
- Software
- Service
Technology Outlook (Revenue: USD Billion; 2018–2028)
- Microarrays
- Polymerase Chain Reaction
- RNA Sequencing
- RNA Interference
Application Outlook (Revenue: USD Billion; 2018–2028)
- Clinical Diagnostics
- Toxicogenomics
- Drug Discovery
- Comparative Transcriptomics
End-use Outlook (Revenue: USD Billion; 2018–2028)
- Hospitals
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
Read More: https://www.emergenresearch.com/industry-report/rna-transcriptomics-market
Related reports:
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkdIn | Twitter | Blogs
